Efg Asset Management (North America) Corp. 10x Genomics, Inc. Transaction History

Efg Asset Management (North America) Corp.

$585 Million
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$36.08 - $54.3 $47,806 - $71,947	1,325 Added 5.98%	23,478 $881,000
Q4 2023 Feb 08, 2024	BUY	$34.32 - $57.55 $162,676 - $272,787	4,740 Added 27.22%	22,153 $1.24 Million
Q3 2023 Nov 02, 2023	BUY	$40.86 - $62.98 $122,580 - $188,940	3,000 Added 20.81%	17,413 $718,000
Q2 2023 Jul 28, 2023	BUY	$50.96 - $58.72 $734,486 - $846,331	14,413 New	14,413 $804,000

Others Institutions Holding TXG

# of Institutions

292

Shares Held

96.6M

Call Options Held

263K

Put Options Held

85.1K

Vanguard Group Inc Valley Forge, PA

11M
Shares

$179 Million
0.0% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

10.8M
Shares

$175 Million
2.31% of portfolio
Morgan Stanley New York, NY

6.48M
Shares

$106 Million
0.01% of portfolio
Black Rock Inc. New York, NY

6.39M
Shares

$104 Million
0.0% of portfolio
Sumitomo Mitsui Trust Holdings, Inc.

6.37M
Shares

$104 Million
0.1% of portfolio

View Full List

About 10x Genomics, Inc.

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.55B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

More about TXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Efg Asset Management (North America) Corp., based on Form 13F filings with the SEC.

News

Stay updated on Efg Asset Management (North America) Corp. with notifications on news.

Account